Global Clinical Trials Support Services Market

Clinical Trials Support Services Market Size, Share, Growth Analysis, By Service (Administrative Staff, Clinical Trial Site Management), By Phase (Phase I, Phase II), By Study Design (Expanded Access, Interventional), By Indication, By Sponsor, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35D2068 | Region: Global | Published Date: December, 2025
Pages: 219 |Tables: 65 |Figures: 78

To request a free sample copy of this report, please complete the form below.

Our Clients

Schineder Electric

KSIA - Korea Semiconductor Industry Association

Hitachi Astemo Limited

Samsung Electronics

Halvo holdings

NTT corporation

AGC Inc

Siemens AG

Unilever

Merck Pharmaceuticals

Atlas Copco

Hologic - Medical Technology company

Novartis

Henkel

Reckitt

Schineder Electric

KSIA - Korea Semiconductor Industry Association

Hitachi Astemo Limited

Samsung Electronics

Halvo holdings

NTT corporation

AGC Inc

Siemens AG

Unilever

Merck Pharmaceuticals

Atlas Copco

Hologic - Medical Technology company

Novartis

Henkel

Reckitt

FAQs

Clinical Trials Support Services Market size was valued at USD 24.84 Billion in 2024 and is poised to grow from USD 26.83 Billion in 2025 to USD 49.66 Billion by 2033, growing at a CAGR of 8% during the forecast period (2026–2033).

Market competition for clinical trials support services is average. The main methods used by players to establish and expand their presence in the clinical trial support services market include growing product launches, partnerships, collaborations, agreements, and market expansions. Alcura Health, Charles River Laboratories, Laboratory Corporation of America Holdings (Covance Inc.), Eurofins Scientific, ICON PLC, Parexel International, PPD Inc., and WuXi PharmaTech are some of the main companies in the market. 'Laboratory Corporation of America Holdings (LabCorp) (USA)', 'Charles River Laboratories International, Inc. (USA) ', 'Syneos Health, Inc. (USA) ', 'Parexel International Corporation (USA) ', 'ICON plc (Ireland) ', 'Wuxi AppTec Co., Ltd. (China) ', 'Eurofins Scientific (Luxembourg) ', 'ACM Global Laboratories (USA) ', 'Clinipace Worldwide (USA) ', 'Worldwide Clinical Trials (USA) ', 'Premier Research (USA) ', 'PSI CRO AG (Switzerland) ', 'Novotech (Australia) ', 'Velocity Clinical Research (USA) ', 'Fortrea (USA) ', 'CTI Clinical Trial and Consulting Services (USA)'

The high burden of infectious and chronic diseases, the high research and development expenditures of pharmaceutical firms, the proliferation of contract research organisations, and the demand for clinical trials in growing countries are the main drivers of the market's growth.

The expanding need for trials in emerging nations, rising R&D investment, and a rise in the number of contract research organisations all point to a rapid expansion of the worldwide market (CROs). Every year, the pharmaceutical companies' (R&D) spending has been continuously rising, mostly as a result of patent expirations.

On the basis of region, Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA).As the majority of the pharmaceutical companies in the United States do the majority of their business in this region, North America dominated the global market in 2021 with the greatest share of 50.4%. Due to the large number of clinical studies being undertaken in the area, this market is most likely to expand. Government funding for clinical trials and large R&D investments are furthering the market's expansion. The expansion of the market in North America has been attributed to the existence of significant CROs that provide clinical trial support services and multinational pharmaceutical and biopharmaceutical companies that make significant expenditures in clinical research. The fastest-growing geographical market over the projection period is expected to be Asia Pacific. The APAC market is driven by a growing patient population, easy administrative compliance, and low cost.

Clinical Trials Support Services Market Size, Share, Growth Analysis, By Service (Administrative Staff, Clinical Trial Site Management), By Phase (Phase I, Phase II), By Study Design (Expanded Access, Interventional), By Indication, By Sponsor, By Region - Industry Forecast 2026-2033

To request a free sample copy of this report, please complete the form below.

Our Clients

FAQs

What is the global market size of Clinical Trials Support Services Market?

Who are the key vendors in the Clinical Trials Support Services Market?

What is the key driver of Clinical Trials Support Services Market?

What is the key market trend for Clinical Trials Support Services Market?

Which region accounted for the largest share in Clinical Trials Support Services Market?

$5,300